With a market cap of has a large market cap size. Allergan plc (NYSE: AGN) has been on the stock market since its IPO date on the 2/17/1993. Allergan plc is in the Drugs – Generic industry and Healthcare sector. Average volume for Allergan plc, is 3063.21, and so far today it has a volume of 2574400. Performance year to date since the 2/17/1993 is -21.94%.
To help you determine whether Allergan plc is undervalued the following values will help you decide. P/E is *TBA and forward P/E is 14.29. PEG perhaps more useful shows that Allergan plc has a value for PEG of *TBA. P/S ratio is 6.28 and the P/B ratio is 1.35. The P/Cash and P/Free cash flow is 190.66 and 21.9 respectively.
At the current price Allergan plc is trading at, 243.94 (0.21% today), Allergan plc has a dividend yield of *TBA, and this is covered by a payout ratio of 0.00%. Earnings per share (EPS) is -6.14, and this is looking to grow in the next year to 21.82% after growing 23.00% this past year. EPS growth quarter over quarter is 9.70%, and 1.50% for sales growth quarter over quarter.
The number of shares outstanding is 395.95, and the number of shares float is 395.29. The senior management bring insider ownership to 0.10%, and institutional ownership is at 87.50%. The float short is 1.68%, with the short ratio at a value of 2.16. Management has seen a return on assets of 3.00%, and also a return on investment of -1.30%.
The ability for Allergan plc, to deal with debt, means it current ratio is 1, and quick ratio is 0.9. Long term debt/equity is 0.52 and total debt/equity is 0.56. In terms of margins, Allergan plc has a gross margin of 78.70%, with its operating margin at -16.50%, and Allergan plc has a profit margin of 27.00%.
The 52 week high is -24.40%, with 24.78% being its 52 week low. The 20 day simple moving average is -0.95% and the 200 day simple moving average is -5.61%.
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.